相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Missing KIR ligands are associated with less relapse and increased graft-versus-host disease (GVHD) following unrelated donor allogeneic HCT
Jeffery S. Miller et al.
BLOOD (2007)
Extended mycophenolate mofetil and shortened cyclosporine failed to reduce graft-versus-host disease after unrelated hematopoietic cell transplantation with nonmyeloablative conditioning
Frederic Baron et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2007)
Impact of conditioning regimen intensity on outcome of allogeneic hematopoietic cell transplantation for advanced acute myelogenous leukemia and myelodyspiastic syndrome
Edwin P. Alyea et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2006)
KIR reconstitution is altered by T cells in the graft and correlates with clinical outcomes after unrelated donor transplantation
S Cooley et al.
BLOOD (2005)
Outcomes of reduced-intensity transplantation for chronic myeloid leukemia: an analysis of prognostic factors from the Chronic Leukemia Working Party of the EBMT
C Crawley et al.
BLOOD (2005)
Protective conditioning for acute graft-versus-host disease
R Lowsky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
CD56dimCD16neg cells are responsible for natural cytotoxicity against tumor targets
O Penack et al.
LEUKEMIA (2005)
Less is more: lymphodepletion followed by hematopoietic stem cell transplant augments adoptive T-cell-based anti-tumor immunotherapy
C Wrzesinski et al.
CURRENT OPINION IN IMMUNOLOGY (2005)
Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning
F Baron et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Sinks, suppressors and antigen presenters: how lymphodepletion enhances T cell-mediated tumor immunotherapy
CA Klebanoff et al.
TRENDS IN IMMUNOLOGY (2005)
Anti-tumour response despite loss of donor chimaerism in patients treated with non-myeloablative conditioning and allogeneic stem cell transplantation
BR Dey et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbidities
ML Sorror et al.
BLOOD (2004)
Graft-versus-myeloma effect following antithymocyte globulin-based reduced intensity conditioning allogeneic stem cell transplantation
M Mohty et al.
BONE MARROW TRANSPLANTATION (2004)
Pharmacokinetics and pharmacodynamics of anti-thymocyte globulin in recipients of partially HLA-matched blood hematopoietic progenitor cell transplantation
EK Waller et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2003)
Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantation
HG Shilling et al.
BLOOD (2003)
Donor lymphocyte infusions mediate superior graft-versus-leukemia effects in mixed compared to fully allogeneic chimeras: a critical role for host antigen-presenting cells
MY Mapara et al.
BLOOD (2002)
Allelic polymorphism synergizes with variable gene content to individualize human KIR genotype
HG Shilling et al.
JOURNAL OF IMMUNOLOGY (2002)
Response of 443 patients to steroids as primary therapy for acute graft-versus-host disease: Comparison of grading systems
ML MacMillan et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2002)
Total and active thymoglobulin levels: effects of dose and sensitization on serum concentrations
JF Regan et al.
TRANSPLANT IMMUNOLOGY (2001)
Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects
PA McSweeney et al.
BLOOD (2001)
Allogeneic bone marrow transplantation from unrelated donors using in vivo anti-T-cell globulin
J Finke et al.
BRITISH JOURNAL OF HAEMATOLOGY (2000)
Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment
T Werkele et al.
NATURE MEDICINE (2000)
Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies
TR Spitzer et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2000)
分享论文
